Jefferies downgraded Sandoz (SDZNY) to Hold from Buy with a price target of CHF 47.60, up from CHF 42.80. The firm views the post-earnings share rally as “excessive.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SDZNY:
- Sandoz Group Reports Strong H1 2025 Financial Results
- Sandoz Group Ltd’s Strategic Growth Amid Market Challenges
- Sandoz to acquire Just-Evotec Biologics from Evotec for $300M
- Sandoz issues recall for additional lot of Cefazolin for injection
- Sandoz breaks ground on new Slovenia facility to expand European biosimilar hub